About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
Classifieds
Weather
Obituaries
Parcel Pickup

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

ASLAN Pharmaceuticals Limited - American Depositary Shares (NQ:ASLN)

0.6000 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ASLAN Pharmaceuticals Limited - American Depositary Shares

< Previous 1 2 3 4 5 6 Next >

12 Health Care Stocks Moving In Friday's After-Market Session ↗

February 24, 2023

Via Benzinga

Why Fulcrum Therapeutics Shares Are Trading Lower By Over 55%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

February 24, 2023

Gainers Bridger Aerospace Group Holdings, Inc. (NASDAQ: BAER) shares jumped 129.6% to $10.15. Jeffrey E. Kelter reported a 22.4% stake in a 13D filing on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 24, 2023

Via Benzinga

ASLAN Pharmaceuticals Presents New Data From Atopic Dermatitis Candidate ↗

September 28, 2022

Via Benzinga

ASLAN Pharma: Q2 Earnings Insights ↗

August 12, 2022

ASLAN Pharma (NASDAQ:ASLN) reported its Q2 earnings results on Friday, August 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 24, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

February 24, 2023

It's time to start off trading on Friday with a breakdown of the biggest pre-market stock movers worth keeping an eye on!

Via InvestorPlace

ASLAN Pharmaceuticals Announces $20M Private Placement Led by BVF Partners L.P. With the Potential to Receive Up to an Additional $80M

February 24, 2023

From ASLAN PHARMACEUTICALS LIMITED

Via GlobeNewswire

ASLAN Pharmaceuticals Announces Completion of Recruitment in Phase 2b TREK-AD Study of Eblasakimab in Atopic Dermatitis Patients

February 24, 2023

From ASLAN PHARMACEUTICALS LIMITED

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

January 30, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 12, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

January 04, 2023

Via Benzinga

Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 04, 2023

Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive...

Via Benzinga

ASLAN Pharmaceuticals and Thermo Fisher Scientific Announce Partnership to Manufacture High Concentration Formulation of Eblasakimab for Future Studies

January 03, 2023

From ASLAN PHARMACEUTICALS LIMITED

Via GlobeNewswire

ASLAN Pharmaceuticals Announces Participation in January Investor Conferences

December 16, 2022

From ASLAN PHARMACEUTICALS LIMITED

Via GlobeNewswire

ASLAN Pharmaceuticals Announces First Patient Screened in Study of Eblasakimab in Dupilumab Experienced Atopic Dermatitis Patients

December 15, 2022

From ASLAN PHARMACEUTICALS LIMITED

Via GlobeNewswire

ASLAN Pharmaceuticals to Participate in a Fireside Chat at 34th Annual Piper Sandler Healthcare Conference

November 21, 2022

From ASLAN PHARMACEUTICALS LIMITED

Via GlobeNewswire

ASLAN Pharmaceuticals to Participate in Jefferies London Healthcare Conference

November 08, 2022

From ASLAN PHARMACEUTICALS LIMITED

Via GlobeNewswire

ASLAN Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update

October 28, 2022

From ASLAN PHARMACEUTICALS LIMITED

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 19, 2022

Gainers ASLAN Pharma (NASDAQ:ASLN) stock moved upwards by 13.7% to $0.54 during Wednesday's after-market session. The market value of their outstanding shares is at $37.6 million.

Via Benzinga

ASLAN Pharmaceuticals Presents New Data on Eblasakimab in Two Late-Breaking e-Posters at the 51st Annual European Society for Dermatological Research Meeting

September 28, 2022

From ASLAN PHARMACEUTICALS LIMITED

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 21, 2022

Gainers Pulmatrix (NASDAQ:PULM) shares rose 11.9% to $4.3 during Wednesday's after-market session. The company's market cap stands at $14.5 million.

Via Benzinga

ASLAN Pharma Starts Eblasakimab Program In Dupixent Treated Dermatitis Patients ↗

September 14, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 12, 2022

Gainers OpGen (NASDAQ:OPGN) shares rose 20.6% to $0.52 during Monday's after-market session. This security traded at a volume of 927.4K shares come close, making up 324.6% of its average volume over...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

September 12, 2022

We're starting off the week with a breakdown of the biggest pre-market stock movers for Monday morning and the news moving them.

Via InvestorPlace

Why Clovis Oncology Is Trading Higher By 14%; Here Are 28 Stocks Moving Premarket ↗

September 12, 2022

Gainers Aditxt, Inc. (NASDAQ: ADTX) rose 46.1% to $0.2801 in pre-market trading after jumping 37% on Friday.

Via Benzinga

Why Nuwellis Surged Over 121%; Here Are 66 Biggest Movers From Yesterday ↗

September 01, 2022

Gainers

Via Benzinga

Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday ↗

August 15, 2022

Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 12, 2022

Via Benzinga

44 Stocks Moving In Thursday's Mid-Day Session: F-star Therapeutics, Revlon And More ↗

June 23, 2022

Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) rose 83.8% to $1.3824. Blue Hat Interactive terminated its previously proposed shelf takedown offering.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

ASLAN Pharmaceuticals Limited - American Depositary Shares (NQ:ASLN)

All News about ASLAN Pharmaceuticals Limited - American Depositary Shares

Sections

Services

Contact Information

Follow Us